Nakhjavani, M.; Hardingham, J.E.; Palethorpe, H.M.; Tomita, Y.; Smith, E.; Price, T.J.; Townsend, A.R.
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer. Medicines 2019, 6, 17.
https://doi.org/10.3390/medicines6010017
AMA Style
Nakhjavani M, Hardingham JE, Palethorpe HM, Tomita Y, Smith E, Price TJ, Townsend AR.
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer. Medicines. 2019; 6(1):17.
https://doi.org/10.3390/medicines6010017
Chicago/Turabian Style
Nakhjavani, Maryam, Jennifer E Hardingham, Helen M Palethorpe, Yoko Tomita, Eric Smith, Tim J Price, and Amanda R Townsend.
2019. "Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer" Medicines 6, no. 1: 17.
https://doi.org/10.3390/medicines6010017
APA Style
Nakhjavani, M., Hardingham, J. E., Palethorpe, H. M., Tomita, Y., Smith, E., Price, T. J., & Townsend, A. R.
(2019). Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer. Medicines, 6(1), 17.
https://doi.org/10.3390/medicines6010017